William Blair Boosts Earnings Estimates for Simulations Plus

Simulations Plus, Inc. (NASDAQ:SLP) – Stock analysts at William Blair increased their Q1 2026 earnings estimates for Simulations Plus in a research report issued to clients and investors on Tuesday, November 5th. William Blair analyst M. Smock now anticipates that the technology company will post earnings per share of $0.19 for the quarter, up from their previous estimate of $0.12. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.11 per share.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same quarter last year, the firm earned $0.18 earnings per share. Simulations Plus’s quarterly revenue was up 19.9% on a year-over-year basis.

Other equities analysts also recently issued research reports about the stock. JMP Securities began coverage on shares of Simulations Plus in a research note on Tuesday, July 16th. They set a “market perform” rating for the company. BTIG Research decreased their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday. Finally, KeyCorp began coverage on shares of Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $54.50.

Simulations Plus Stock Up 7.8 %

Shares of NASDAQ SLP opened at $30.82 on Thursday. Simulations Plus has a twelve month low of $27.22 and a twelve month high of $51.22. The firm has a fifty day simple moving average of $31.82 and a 200 day simple moving average of $39.60. The company has a market capitalization of $618.56 million, a PE ratio of 62.90 and a beta of 0.71.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. nVerses Capital LLC boosted its holdings in Simulations Plus by 1,100.0% during the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock worth $38,000 after purchasing an additional 1,100 shares during the last quarter. EntryPoint Capital LLC bought a new stake in Simulations Plus in the first quarter worth about $57,000. Allspring Global Investments Holdings LLC bought a new stake in Simulations Plus in the first quarter worth about $70,000. US Bancorp DE raised its position in Simulations Plus by 37.0% in the third quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock worth $159,000 after acquiring an additional 1,343 shares during the period. Finally, Los Angeles Capital Management LLC bought a new stake in shares of Simulations Plus in the second quarter valued at approximately $206,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total transaction of $625,200.00. Following the completion of the transaction, the director now directly owns 3,481,592 shares in the company, valued at $108,834,565.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 60,750 shares of company stock worth $1,905,655 over the last three months. 20.90% of the stock is currently owned by insiders.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.